品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
阿拉丁 | A128022-5mg | 5mg | 现货 | 1097917-15-1 |
ASP3026,间变性间变性淋巴瘤激酶(ALK)抑制剂 ASP3026 |
Moligand™, ≥98% |
|
|
阿拉丁 | A128022-25mg | 25mg | 现货 | 1097917-15-1 |
ASP3026,间变性间变性淋巴瘤激酶(ALK)抑制剂 ASP3026 |
Moligand™, ≥98% |
|
|
阿拉丁 | A128022-100mg | 100mg | 现货 | 1097917-15-1 |
ASP3026,间变性间变性淋巴瘤激酶(ALK)抑制剂 ASP3026 |
Moligand™, ≥98% |
|
|
阿拉丁 | A420576-1ml | 1ml | 现货 | 1097917-15-1 |
ASP3026 ASP3026 |
Moligand™, 10mM in DMSO |
|
|
阿拉丁 | A128022-1mg | 1mg | 现货 | 1097917-15-1 |
ASP3026,间变性间变性淋巴瘤激酶(ALK)抑制剂 ASP3026 |
Moligand™, ≥98% |
|
|
麦克林 | A864163-5mg | 5mg | 订前询问 | 1097917-15-1 |
ASP3026 ASP3026 |
≥98% |
|
|
罗恩 | R031992-25mg | 25mg | 5~7个工作日 | 1097917-15-1 |
N2-[2-甲氧基-4-[4-(4-甲基-1-哌嗪基)-... 2-N-[2-methoxy-4-[4-(4-methy... |
98% |
|
|
罗恩 | R031992-5mg | 5mg | 5~7个工作日 | 1097917-15-1 |
N2-[2-甲氧基-4-[4-(4-甲基-1-哌嗪基)-... 2-N-[2-methoxy-4-[4-(4-methy... |
98% |
|
|
MARY | MR14210103-25mg | 25mg | 订前咨询 | 1097917-15-1 |
N2-[2-甲氧基-4-[4-(4-甲基-1-哌嗪基)-... 2-N-[2-methoxy-4-[4-(4-methy... |
98% |
|
|
MARY | MR14210103-5mg | 5mg | 订前咨询 | 1097917-15-1 |
N2-[2-甲氧基-4-[4-(4-甲基-1-哌嗪基)-... 2-N-[2-methoxy-4-[4-(4-methy... |
98% |
|
|
源叶 | S80091-2mg | 2mg | 现货 | 1097917-15-1 |
ASP3026 ASP3026 |
99% |
|
|
源叶 | S80091-5mg | 5mg | 现货 | 1097917-15-1 |
ASP3026 ASP3026 |
99% |
|
|
源叶 | S80091-10mg | 10mg | 现货 | 1097917-15-1 |
ASP3026 ASP3026 |
99% |
|
|
源叶 | S80091-25mg | 25mg | 现货 | 1097917-15-1 |
ASP3026 ASP3026 |
99% |
|
|
源叶 | S80091-50mg | 50mg | 现货 | 1097917-15-1 |
ASP3026 ASP3026 |
99% |
|
|
源叶 | S80091-100mg | 100mg | 期货,请咨询 | 1097917-15-1 |
ASP3026 ASP3026 |
99% |
|
|
源叶 | T92283-1ml | 1ml | 期货,请咨询 | 1097917-15-1 |
ASP3026 ASP3026 |
10mM in DMSO |
|
|
毕得 | BD558645-5mg | 5mg | 现货 | 1097917-15-1 |
N2-(2-(异丙基磺酰基)苯基)-N4-(2-甲氧基-... N2-(2-(Isopropylsulfonyl)phe... |
98+% |
|
|
毕得 | BD558645-10mg | 10mg | 现货 | 1097917-15-1 |
N2-(2-(异丙基磺酰基)苯基)-N4-(2-甲氧基-... N2-(2-(Isopropylsulfonyl)phe... |
98+% |
|
|